Drugs / DMT310
Trials 4 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 23 trials | ||||||
| Phase 2 | NCT05108025 | Nov 2021 → Dec 2022 | rosacea | Dermata Therapeutics | Unknown | No outcome recorded |
| Phase 2 | NCT04106778 | Oct 2019 → May 2020 | acne | Dermata Therapeutics | Completed | No outcome recorded |
| Phase 2 | NCT03536637 | May → Dec 2018 | acne | Dermata Therapeutics | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT06090721 | Dec 2023 → Mar 2025 | acne | Dermata Therapeutics | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DMT310 | “DMT310 Powder mixed with Hydrogen Peroxide” NCT05108025 ↗ |
| Route | Topical | “DMT310 topical powder mixed with diluent” NCT03536637 ↗ |